Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aggression, mania, and hypomania induction associated with atomoxetine.

× No keyword cloud information.

11 in total

Review 1. Pharmacological management of attention-deficit hyperactivity disorder in adolescents: special considerations.

Authors: Philip Hazell
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

2. Treatment of ADHD in patients with bipolar disorder.

Authors: Rachel Girard; Ridha Joober
Journal: J Psychiatry Neurosci Date: 2017-11 Impact factor: 6.186

3. Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review.

Authors: Katherine E McDonell; Cyndya A Shibao; Italo Biaggioni; Adam Hartman; David Robertson; Daniel O Claassen
Journal: Cogn Behav Neurol Date: 2019-09 Impact factor: 1.600

Review 4. Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors: Johnny Graham; David Coghill
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

Review 5. Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.

Authors: Robert L Findling; Shawn A Candler; Azmi F Nasser; Stefan Schwabe; Chungping Yu; Jennie Garcia-Olivares; Welton O'Neal; Jeffrey H Newcorn
Journal: CNS Drugs Date: 2021-05-18 Impact factor: 5.749

Review 6. Lifetime evolution of ADHD treatment.

Authors: Federico Mucci; Barbara Carpita; Giovanni Pagni; Alessandra Della Vecchia; Sarah Bjedov; Andrea Pozza; Donatella Marazziti
Journal: J Neural Transm (Vienna) Date: 2021-05-15 Impact factor: 3.850

7. Atomoxetine Induced Hypomania in a Patient with Bipolar Disorder and Adult Attention Deficit Hyperactivity Disorder.

Authors: Vijaya Kumar; Shivarama Varambally
Journal: Indian J Psychol Med Date: 2017 Jan-Feb

8. Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder.

Authors: Kee Jeong Park; Hyo-Won Kim
Journal: Soa Chongsonyon Chongsin Uihak Date: 2019-03-31

9. SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts.

Authors: Daniel G Amen; Theodore A Henderson; Andrew Newberg
Journal: Front Psychiatry Date: 2021-11-24 Impact factor: 4.157

10. Atomoxetine: a novel treatment for child and adult ADHD.

Authors: Marcialee Ledbetter
Journal: Neuropsychiatr Dis Treat Date: 2006-12 Impact factor: 2.570